Japan's Regenerative Medicine Market To Hit Y1.6tln In 2030

TOKYO (Kyodo)--Japan's regenerative medicine market is projected to total 1.6 trillion yen in 2030, up from 26 billion yen in 2012, with products made from human cells set to increase in variety and those from artificially derived multipurpose stem cells likely to be commercialized, the industry ministry said Friday.